Evidence-Based Medicine Guidelines
Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma
Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Long-acting Beta2-agonists Versus Anti-leukotrienes as Add-on Therapy to Inhaled Corticosteroids for Chronic Asthma." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451501/all/_________Long_acting_beta2_agonists_versus_anti_leukotrienes_as_add_on_therapy_to_inhaled_corticosteroids_for_chronic_asthma______.
Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451501/all/_________Long_acting_beta2_agonists_versus_anti_leukotrienes_as_add_on_therapy_to_inhaled_corticosteroids_for_chronic_asthma______. Accessed January 18, 2020.
Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/451501/all/_________Long_acting_beta2_agonists_versus_anti_leukotrienes_as_add_on_therapy_to_inhaled_corticosteroids_for_chronic_asthma______
Long-acting Beta2-agonists Versus Anti-leukotrienes as Add-on Therapy to Inhaled Corticosteroids for Chronic Asthma [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2020 January 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451501/all/_________Long_acting_beta2_agonists_versus_anti_leukotrienes_as_add_on_therapy_to_inhaled_corticosteroids_for_chronic_asthma______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma
ID - 451501
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451501/all/_________Long_acting_beta2_agonists_versus_anti_leukotrienes_as_add_on_therapy_to_inhaled_corticosteroids_for_chronic_asthma______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -